Abstract
The lipoic acid (lipoate) coenzyme is unique in all of mammalian metabolism. It is not only crucial to the function of some of the major enzymes feeding carbon into the tricarboxylic acid cycle, but also generates dynamic regulatory information about the metabolic status of the mitochondrial matrix, ultimately functioning to control these metabolic fluxes. Moreover, these lipoate-sensitive regulatory processes are apparently systematically redesigned in tumor cells and the affected enzymes commonly become especially central to cancer metabolism. Thus, lipoate-sensitive regulatory processes constitute potentially uniquely valuable targets for chemotherapeutic attack. Our goal here is to review the current status of our knowledge relevant to the use of lipoate and lipoate analogs to therapeutically attack malignant disease.
| Original language | English |
|---|---|
| Pages (from-to) | 837-846 |
| Number of pages | 10 |
| Journal | Expert Review of Clinical Pharmacology |
| Volume | 7 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 1 2014 |
Keywords
- cancer metabolism
- chemotherapy
- lipoate
- lipoate analogs
- lipoic acid
- lipoic acid analogs
- tumor mitochondria
- two compartment metabolism
Fingerprint
Dive into the research topics of 'Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver